• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人毛细胞型星形细胞瘤的分子时代:全面综述。

Adult pilocytic astrocytoma in the molecular era: a comprehensive review.

机构信息

Department of Medicine, Neurology, Madigan Army Medical Center, Tacoma, WA 98431, USA.

University of Rochester School of Medicine & Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA.

出版信息

CNS Oncol. 2021 Mar 1;10(1):CNS68. doi: 10.2217/cns-2020-0027. Epub 2021 Jan 15.

DOI:10.2217/cns-2020-0027
PMID:33448230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7962176/
Abstract

Adult pilocytic astrocytoma (PA) is less prevalent than pediatric PA and is associated with a worse prognosis. In a literature review, we found that 88.3% of the molecular alterations in adult PA are associated with MAPK pathway dysregulation. The most common alterations are fusions of . Understanding of the mechanisms underlying this pathway has evolved substantially, heralding advancements in specific targeted therapy. Here, we review clinical and molecular features of adult PA, characteristics predicting aggressive behavior and approaches to standard and investigational therapies. We highlight epigenetic profiling and integrated diagnosis as an essential component of classifying PA.

摘要

成人毛细胞型星形细胞瘤(PA)比儿童 PA 少见,且预后较差。在文献回顾中,我们发现 88.3%的成人 PA 的分子改变与 MAPK 通路失调有关。最常见的改变是. 对该通路相关机制的认识已经有了很大的发展,预示着特定靶向治疗的进步。在这里,我们回顾成人 PA 的临床和分子特征、预测侵袭性行为的特征以及标准和研究性治疗方法。我们强调表观遗传谱分析和综合诊断是 PA 分类的一个重要组成部分。

相似文献

1
Adult pilocytic astrocytoma in the molecular era: a comprehensive review.成人毛细胞型星形细胞瘤的分子时代:全面综述。
CNS Oncol. 2021 Mar 1;10(1):CNS68. doi: 10.2217/cns-2020-0027. Epub 2021 Jan 15.
2
Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.毛细胞型星形细胞瘤:一种具有不断演变的分子异质性的疾病。
J Child Neurol. 2013 May;28(5):625-32. doi: 10.1177/0883073813476141. Epub 2013 Feb 25.
3
MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.MAPK 通路通过 BRAF 基因融合在毛细胞星形细胞瘤中的激活;一种具有诊断、预后和治疗潜力的新型致癌融合基因。
J Pathol. 2010 Dec;222(4):324-8. doi: 10.1002/path.2780.
4
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.BRAF和IDH1的联合分子分析可将毛细胞型星形细胞瘤与弥漫性星形细胞瘤区分开来。
Acta Neuropathol. 2009 Sep;118(3):401-5. doi: 10.1007/s00401-009-0550-z. Epub 2009 Jun 19.
5
A novel GIT2-BRAF fusion in pilocytic astrocytoma.毛细胞型星形细胞瘤中的一种新型GIT2-BRAF融合基因。
Diagn Pathol. 2017 Nov 15;12(1):82. doi: 10.1186/s13000-017-0669-5.
6
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.7q34 缺失导致的致癌性 FAM131B-BRAF 融合构成了毛细胞星形细胞瘤中 MAPK 通路激活的另一种机制。
Acta Neuropathol. 2011 Jun;121(6):763-74. doi: 10.1007/s00401-011-0817-z. Epub 2011 Mar 20.
7
A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.一种新的GTF2I-BRAF融合体介导毛细胞型星形细胞瘤中的MAPK通路激活。
PLoS One. 2017 Apr 27;12(4):e0175638. doi: 10.1371/journal.pone.0175638. eCollection 2017.
8
The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.具有非典型特征的毛细胞星形细胞瘤与恶性神经胶质瘤的鉴别诊断:16 例病例分析,重点在于区分分子特征。
J Neurooncol. 2013 Dec;115(3):477-86. doi: 10.1007/s11060-013-1249-5. Epub 2013 Sep 21.
9
KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.KIAA1549:BRAF基因融合和FGFR1热点突变是毛细胞型星形细胞瘤的预后因素。
J Neuropathol Exp Neurol. 2015 Jul;74(7):743-54. doi: 10.1097/NEN.0000000000000213.
10
Molecular characterization of disseminated pilocytic astrocytomas.弥漫性毛细胞型星形细胞瘤的分子特征
Neuropathol Appl Neurobiol. 2016 Apr;42(3):273-8. doi: 10.1111/nan.12256. Epub 2015 Jul 20.

引用本文的文献

1
Clinical and genomic factors differ in pediatric and adult pilocytic astrocytoma: a single-center experience with over 350 patients.小儿与成人毛细胞型星形细胞瘤的临床和基因组因素存在差异:一项针对350多名患者的单中心经验。
J Neurooncol. 2025 Aug 8. doi: 10.1007/s11060-025-05145-3.
2
Multinodular and Vacuolating Neuronal Tumors: Imaging Features, Diagnosis, and Management Challenges.多结节性和空泡性神经元肿瘤:影像学特征、诊断及管理挑战
Diagnostics (Basel). 2025 Jan 31;15(3):334. doi: 10.3390/diagnostics15030334.
3
Analysis of Spinal Pilocytic Astrocytoma in 12 Case Reports and Literature Review.

本文引用的文献

1
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.NF106:神经纤维瘤病临床试验联盟的一项 II 期试验,评估 MEK 抑制剂 Mirdametinib(PD-0325901)在 NF1 相关丛状神经纤维瘤的青少年和成人患者中的疗效。
J Clin Oncol. 2021 Mar 1;39(7):797-806. doi: 10.1200/JCO.20.02220. Epub 2021 Jan 28.
2
Response to trametinib treatment in progressive pediatric low-grade glioma patients.进展性小儿低级别胶质瘤患者对曲美替尼治疗的反应。
J Neurooncol. 2020 Sep;149(3):499-510. doi: 10.1007/s11060-020-03640-3. Epub 2020 Oct 7.
3
12例脊髓毛细胞型星形细胞瘤病例分析及文献综述
J Belg Soc Radiol. 2024 Sep 18;108(1):82. doi: 10.5334/jbsr.3328. eCollection 2024.
4
The Role of Radiotherapy, Chemotherapy, and Targeted Therapies in Adult Intramedullary Spinal Cord Tumors.放疗、化疗及靶向治疗在成人脊髓髓内肿瘤中的作用
Cancers (Basel). 2024 Aug 6;16(16):2781. doi: 10.3390/cancers16162781.
5
Hypothalamic Hemangioma-like Pilocytic Astrocytoma in an Adult Patient: A Systematic Review with a Focus on Differential Diagnosis and Neurological Presentation.成年患者下丘脑海绵状毛细胞型星形细胞瘤:一项侧重于鉴别诊断和神经学表现的系统评价
J Clin Med. 2024 Jun 17;13(12):3536. doi: 10.3390/jcm13123536.
6
MEK Inhibition in a Pilocytic Astrocytoma With a Rare Mutation in a Young Adult Patient: A Case Report.MEK 抑制治疗罕见突变毛细胞星形细胞瘤 1 例报告
JCO Precis Oncol. 2024 Jun;8:e2400174. doi: 10.1200/PO.24.00174.
7
Rare vermian pilocytic astrocytoma with recurrent spontaneous hemorrhage in the elderly: A case report and review of literature.老年罕见的小脑蚓部毛细胞型星形细胞瘤伴复发性自发性出血:一例报告并文献复习
Surg Neurol Int. 2024 Mar 15;15:90. doi: 10.25259/SNI_978_2023. eCollection 2024.
8
Pediatric-Like Brain Tumors in Adults.成人中的类脑瘤。
Adv Tech Stand Neurosurg. 2024;50:147-183. doi: 10.1007/978-3-031-53578-9_5.
9
Pilocytic astrocytoma: The paradigmatic entity in low‑grade gliomas (Review).毛细胞型星形细胞瘤:低级别胶质瘤中的典型实体(综述)
Oncol Lett. 2024 Feb 8;27(4):146. doi: 10.3892/ol.2024.14279. eCollection 2024 Apr.
10
Rare Neuronal, Glial and Glioneuronal Tumours in Adults.成人罕见的神经元、神经胶质和神经胶质神经元肿瘤。
Cancers (Basel). 2023 Feb 9;15(4):1120. doi: 10.3390/cancers15041120.
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
全面分析伴有 FGFR1 改变的多种低级别神经上皮肿瘤,揭示出具有神经胶-神经元肿瘤特征的独特分子特征。
Acta Neuropathol Commun. 2020 Aug 28;8(1):151. doi: 10.1186/s40478-020-01027-z.
4
Dual inhibition of BRAF and mTOR in -mutant pediatric, adolescent, and young adult brain tumors.BRAF 和 mTOR 双重抑制治疗 - 突变型儿童、青少年和青年脑肿瘤。
Cold Spring Harb Mol Case Stud. 2020 Aug 25;6(4). doi: 10.1101/mcs.a005041. Print 2020 Aug.
5
Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases.弥漫性软脑膜胶质神经元肿瘤:双重错误命名?两例报告。
Acta Neuropathol Commun. 2020 Jun 30;8(1):95. doi: 10.1186/s40478-020-00978-7.
6
Quest for Clinically Effective RAF Dimer Inhibitors.寻找临床有效的RAF二聚体抑制剂。
J Clin Oncol. 2020 Jul 1;38(19):2197-2200. doi: 10.1200/JCO.20.00401. Epub 2020 May 20.
7
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma.成人毛细胞型星形细胞瘤的临床特征和预后因素。
J Neurooncol. 2020 May;148(1):187-198. doi: 10.1007/s11060-020-03513-9. Epub 2020 Apr 27.
8
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.cIMPACT-NOW更新6:关于未来中枢神经系统肿瘤分类和分级的cIMPACT-乌得勒支会议的新实体和诊断原则建议。
Brain Pathol. 2020 Jul;30(4):844-856. doi: 10.1111/bpa.12832. Epub 2020 Apr 19.
9
KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?KRAS G12C 权游,谁是 KRAS 抑制剂的铁王座之王?
Cancer Treat Rev. 2020 Mar;84:101974. doi: 10.1016/j.ctrv.2020.101974. Epub 2020 Jan 23.
10
Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.顶盖胶质瘤中KRAS G12R以及KRAS和BRAF同时发生改变的发生率很高。
Acta Neuropathol. 2020 Mar;139(3):601-602. doi: 10.1007/s00401-019-02112-x. Epub 2019 Dec 10.